Gotowa bibliografia na temat „Antiphospholipid syndrome”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Antiphospholipid syndrome”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Antiphospholipid syndrome"

1

Dutra, Livia Almeida, Pedro Braga-Neto, José Luiz Pedroso, and Orlando Graziani Povoas Barsottini. "Sneddon's syndrome: case report and review of its relationship with antiphospholipid syndrome." Einstein (São Paulo) 10, no. 2 (2012): 230–32. http://dx.doi.org/10.1590/s1679-45082012000200018.

Pełny tekst źródła
Streszczenie:
The Sneddon's syndrome is a rare disorder characterized by the occurrence of cerebrovascular disease associated with livedo reticularis. The antiphospholipid syndrome is the most frequent type of acquired thrombophilia, defined by the occurrence of thrombosis or pregnancy morbidity in the presence of persistently positive antiphospholipid antibodies. Approximately 80% of Sneddon's syndrome patients have an antiphospholipid antibody marker. These antibodies may play a pathogenetic role in some cases of Sneddon's syndrome, and many authors consider these two syndromes as the same entity. Althoug
Style APA, Harvard, Vancouver, ISO itp.
2

B, Aswin, Sumanth T, and Ravi Madhusudhana. "Pregnancy and Antiphospholipid Antibody Syndrome." Indian Journal of Anesthesia and Analgesia 9, no. 3 (2022): 41–43. http://dx.doi.org/10.21088/ijaa.2349.8471.9322.14.

Pełny tekst źródła
Streszczenie:
Introduction: ALPA is an autoimmune hypercoagulable state caused by antiphospholipid antibodies. It is characterized by thrombotic episodes in arteries, veins and pregnancy related complications like still birth, preterm delivery, miscarriage and severe preeclampsia. We report a case of APLA syndrome due to its rarity. Case Report: A 28 year old woman with a history of two previous abortions and positive serology for APLAs with 9 months gestation came to our hospital for safe confinement. She was diagnosed as primary APLA syndrome in view of bad obstetric history and positive lupus anticoagula
Style APA, Harvard, Vancouver, ISO itp.
3

Khamashta, Munther A., and Graham R. V. Hughes. "Antiphospholipid antibodies and antiphospholipid syndrome." Current Opinion in Rheumatology 7, no. 5 (1995): 389–94. http://dx.doi.org/10.1097/00002281-199509000-00005.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Pavlovic, Dragan, and Aleksandra Pavlovic. "Antiphospholipid syndrome." Srpski arhiv za celokupno lekarstvo 138, no. 9-10 (2010): 651–57. http://dx.doi.org/10.2298/sarh1010651p.

Pełny tekst źródła
Streszczenie:
Antiphospholipid syndrome (APS) is an autoimmune disease with recurrent thromboses and pregnancy complications (90% are female patients) that can be primary and secondary (with concomitant autoimmune disease). Antiphospholipid antibodies are prothrombotic but also act directly with brain tissue. One clinical and one laboratory criterion is necessary for the diagnosis of APS. Positive serological tests have to be confirmed after at least 12 weeks. Clinical picture consists of thromboses in many organs and spontaneous miscarriages, sometimes thrombocytopaenia and haemolytic anaemia, but neurolog
Style APA, Harvard, Vancouver, ISO itp.
5

IKEDA, Yasuo. "Antiphospholipid Syndrome." Japanese Journal of Thrombosis and Hemostasis 2, no. 2 (1991): 112–21. http://dx.doi.org/10.2491/jjsth.2.112.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

ABE, Nobuya, and Tatsuya ATSUMI. "Antiphospholipid syndrome." Japanese Journal of Thrombosis and Hemostasis 29, no. 3 (2018): 294–306. http://dx.doi.org/10.2491/jjsth.29.294.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Santos, Thaís da Silva, Izabel Galhardo Demarchi, Tatiane França Perles Mello, Jorge Juarez Vieira Teixeira, and Maria Valdrinez Campana Lonardoni. "Antiphospholipid Syndrome." REVISTA CIÊNCIAS EM SAÚDE 9, no. 4 (2019): 37–42. http://dx.doi.org/10.21876/rcshci.v9i4.892.

Pełny tekst źródła
Streszczenie:
Antiphospholipid syndrome (APS) was characterized as an autoimmune condition with the production of antiphospholipid antibodies (aPL) associated with thrombosis and morbidity in pregnancy. The prevalence of aPL in the population ranges from 1% to 5% in patients with APS. The hypotheses regarding pathophysiological mechanisms are strongly related to binding proteins and antiphospholipid antibodies. The exact mechanisms by which they lead to clinical manifestations appear to be heterogeneous, but it is believed which aPL contribute to the cellular activation/coagulation, and so cause the thrombo
Style APA, Harvard, Vancouver, ISO itp.
8

ICHIKAWA, Kenji, Akito TSUTSUMI, Eiji MATSUURA, and Takao KOIKE. "Antiphospholipid Syndrome." Internal Medicine 38, no. 2 (1999): 170–73. http://dx.doi.org/10.2169/internalmedicine.38.170.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Makarenko, E. V. "ANTIPHOSPHOLIPID SYNDROME." Health and Ecology Issues, no. 4 (December 28, 2017): 4–11. http://dx.doi.org/10.51523/2708-6011.2017-14-4-1.

Pełny tekst źródła
Streszczenie:
Antiphospholipid syndrome is autoimmune acquired thrombophilia associated with the formation of antibodies to phospholipids, which is manifested by recurrent venous or arterial thrombosis and/or pathology of pregnancy. Antiphospholipid antibodies are a heterogeneous group of autoantibodies interacting with phospholipids, which are components of cell membranes and phospholipid-binding proteins of blood plasma. Antiphospholipid syndrome can affect vessels of any caliber and localization, with thrombosis accompanied by no morphological signs of inflammation in the wall of the vessel. Obstetrical
Style APA, Harvard, Vancouver, ISO itp.
10

Koike, Takao. "Antiphospholipid syndrome." Ensho 20, no. 5 (2000): 571–80. http://dx.doi.org/10.2492/jsir1981.20.571.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Antiphospholipid syndrome"

1

Dennen, Gabrielle. "Assessment of perinatal nurses' knowledge of antiphospholipid syndrome and nursing management of pregnant women with antiphospholipid syndrome." Honors in the Major Thesis, University of Central Florida, 2013. http://digital.library.ucf.edu/cdm/ref/collection/ETH/id/841.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Ames, Paul Richard Julian. "Atherogenesis and atherosclerosis in primary antiphospholipid syndrome." Doctoral thesis, Faculdade de Ciências Médicas. UNL, 2013. http://hdl.handle.net/10362/10293.

Pełny tekst źródła
Streszczenie:
ABSTRACT: In the late seventies the term “Haematological Stress Syndrome” defined some haematological abnormalities appearing in the course of acute and chronic disorders, such as raised plasma levels of fibrinogen (FNG) and factor VIII, reduced fibrinolytic activity and hyperviscosity. In the early nineties the “Membrane stress syndrome hypothesis” proposed the unification of the concepts of haematological stress syndrome with those of oxidation, inflammation and immune activation to explain the pathogenesis of the antiphospholipid syndrome (APS) Antiphospholipid antibodies, coagulation, fib
Style APA, Harvard, Vancouver, ISO itp.
3

Gómez, Puerta José Alfredo. "Antiphospholipid Syndrome: Expanding the Spectrum of Autoimmune Thrombosis." Doctoral thesis, Universitat de Barcelona, 2007. http://hdl.handle.net/10803/2227.

Pełny tekst źródła
Streszczenie:
The antiphospholipid syndrome (APS) is an acquired prothrombotic syndrome characterized by venous or arterial thromboses and pregnancy morbidity. It can present as primary APS without any discernable underlying disease, or in association with systemic autoimmune disease [usually systemic lupus erythematosus (SLE)], infections (mainly chronic viral infections) and malignant process, among others. It may also occur rapidly over days or weeks, when it is known as "catastrophic" APS (CAPS).<br/>The first study described one of the largest known cohorts of patients with primary APS from 4 different
Style APA, Harvard, Vancouver, ISO itp.
4

Poulton, K. S. "Understanding mechanisms of cellular injury in the antiphospholipid syndrome." Thesis, University College London (University of London), 2013. http://discovery.ucl.ac.uk/1396605/.

Pełny tekst źródła
Streszczenie:
Patients with the Antiphospholipid Syndrome (APS) have circulating antiphospholipid antibodies (aPL) which cause vascular thrombosis (VT) and/or pregnancy morbidity (PM). Previously we have shown that IgG isolated from patients with APS and VT alone (APS-VT) caused activation of p38 MAPK and NFκB signalling pathways and up-regulation of tissue factor (TF) activity in monocytes. These effects were not seen with IgG from patients with APS and PM alone (APS-PM) or healthy controls. TF up-regulation caused by the APS-VT samples was reduced by p38 MAPK, NFκB, and TLR4 inhibitors, thus implicating a
Style APA, Harvard, Vancouver, ISO itp.
5

Donohoe, Siobhan. "An investigation of antiphospholipid antibody associated obstetric complications." Thesis, University College London (University of London), 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.312964.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Giannakopoulos, Bill Clinical School St George Hospital Faculty of Medicine UNSW. "Investigations on beta 2-glycoprotein I and antiphospholipid antibodies." Publisher:University of New South Wales. Clinical School - St George Hospital, 2008. http://handle.unsw.edu.au/1959.4/41440.

Pełny tekst źródła
Streszczenie:
An outline of the work contained in this thesis is presented. The first chapter is a critical review of the literature pertaining to the pathophysiological mechanisms operational with regards to the antiphospholipid syndrome (APS). The syndrome is characterised by venous and arterial thrombosis, and recurrent fetal loss, in association with the persistent presence of antibodies targeting the main autoantigen beta 2-glycoprotein I (β2GPI). The second chapter reviews the literature delineating the diverse physiological functions of β2GPI, and then relates them to its role in our current understa
Style APA, Harvard, Vancouver, ISO itp.
7

Tolomeo, Tanya. "The role of beta2-glycoprotein I-reactive T cells in antiphospholipid syndrome." Thesis, McGill University, 2008. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=19246.

Pełny tekst źródła
Streszczenie:
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence of autoantibodies to phospholipid (PL)-binding proteins, such as beta2-glycoprotein I (beta2GPI), and clinical manifestations including thrombosis and/or recurrent pregnancy loss. Beta2GPI-reactive T cells have been shown to be activated in patients with APS, but the mechanism responsible for this activation remains unclear. Recent studies have proposed that exposure of a cryptic epitope on beta2GPI, as a consequence of binding to PL, l
Style APA, Harvard, Vancouver, ISO itp.
8

Miranda, Sébastien. "Modulation de la dysfonction endothéliale et de l'altération du glycocalyx endothélial au cours du Syndrome des Antiphospholipides primaire artériel.Approche translationnelle et aspects pharmacologiques Infliximab improves endothelial dysfunction in a mouse model of antiphospholipid syndrome: role of reduced oxidative stress. New insights into antiphospholipid related endothelial dysfunction by assessment of vascular glycocalyx layer. Results from a preliminary case control study." Thesis, Normandie, 2019. http://www.theses.fr/2019NORMR006.

Pełny tekst źródła
Streszczenie:
Ce travail a permis chez des patients atteints d'un SAPL artériel primaire mais également dansdes modèles de cultures cellulaires et dans un modèle murin de SAPL de confirmer l'existence d'unedysfonction endothéliale et de montrer pour la première fois l’altération du GCX endothélial.L'implication de l’altération du GCX dans la survenue d'une dysfonction endothéliale, d'un étatpro-thrombotique permanent à distance de toute poussée de la maladie a pu être établie de façondirecte tant au niveau clinique qu'expérimental tout comme son association au développement d'uneathérosclérose précoce infra
Style APA, Harvard, Vancouver, ISO itp.
9

Harris, Simon Leigh. "The antigenic binding site of antibodies to factor XII associated with antiphospholipid syndrome." Thesis, University of Kent, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.399595.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Pereira, Delgado Alves Jose Antonio. "Oxidative stress and vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome." Thesis, University College London (University of London), 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.412911.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Antiphospholipid syndrome"

1

Erkan, Doruk, and Silvia S. Pierangeli, eds. Antiphospholipid Syndrome. Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-3194-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Erkan, Doruk, and Michael D. Lockshin, eds. Antiphospholipid Syndrome. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55442-6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

service), ScienceDirect (Online, ed. Antiphospholipid syndrome in systemic autoimmune diseases. Elsevier, 2009.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

A, Asherson Ronald, ed. The antiphospholipid syndrome. CRC Press, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

A, Khamashta Munther, ed. Hughes syndrome: Antiphospholipid syndrome. Springer, 2000.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Khamashta, M. A., Maria L. Bertolaccini, and Oier Ateka-Barrutia. Antiphospholipid Syndrome Handbook. Springer London, 2010. http://dx.doi.org/10.1007/978-1-84628-735-0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Meroni, Pier Luigi, ed. Antiphospholipid Antibody Syndrome. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-11044-8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

A, Khamashta Munther, ed. Antiphospholipid (Hughes) syndrome. Saunders, 2001.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

A, Khamashta Munther, ed. Antiphospholipid (Hughes) syndrome. Saunders, 2006.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Hughes, Graham, and Shirish Sangle. Hughes Syndrome: The Antiphospholipid Syndrome. Springer London, 2012. http://dx.doi.org/10.1007/978-0-85729-739-6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Antiphospholipid syndrome"

1

Lockshin, Michael D., and E. Nigel Harris. "History of Antiphospholipid Antibody." In Antiphospholipid Syndrome. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55442-6_1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Yelnik, Cécile M., Simone Appenzeller, Giovanni Sanna, Elizabeth Kozora, and Maria Laura Bertolaccini. "Neuropsychiatric Manifestations of Antiphospholipid Syndrome." In Antiphospholipid Syndrome. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55442-6_10.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Crowther, Mark, Kimberly J. Legault, David A. Garcia, et al. "Prevention and Treatment of Thrombotic Antiphospholipid Syndrome." In Antiphospholipid Syndrome. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55442-6_11.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

de Jesús, Guilherme Ramires, Karen J. Gibbins, Robert M. Silver, and D. Ware Branch. "Prevention and Treatment of Obstetric Antiphospholipid Syndrome." In Antiphospholipid Syndrome. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55442-6_12.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Ugolini-Lopes, Michelle Remião, Paulo Ricardo Criado, Kurosh Parsi, et al. "Treatment of Non-criteria Manifestations in Antiphospholipid Syndrome." In Antiphospholipid Syndrome. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55442-6_13.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Barbhaiya, Medha, Danieli Andrade, Maria Laura Bertolaccini, and Doruk Erkan. "Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION)." In Antiphospholipid Syndrome. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55442-6_14.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Zuily, Stéphane, Medha Barbhaiya, Karen H. Costenbader, and Doruk Erkan. "15th International Congress on Antiphospholipid Antibodies Task Force on Antiphospholipid Syndrome Classification Report." In Antiphospholipid Syndrome. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55442-6_15.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Soybilgic, Arzu, Cassyanne L. Aguiar, M. Patricia Massicotte, et al. "15th International Congress on Antiphospholipid Antibodies Task Force on Pediatric Antiphospholipid Syndrome Report." In Antiphospholipid Syndrome. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55442-6_16.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Cervera, Ricard, Ignasi Rodríguez Pintó, Gerard Espinosa, et al. "15th International Congress on Antiphospholipid Antibodies Task Force on Catastrophic Antiphospholipid Syndrome Report." In Antiphospholipid Syndrome. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55442-6_17.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Andrade, Danieli, Ricard Cervera, Hannah Cohen, et al. "15th International Congress on Antiphospholipid Antibodies Task Force on Antiphospholipid Syndrome Treatment Trends Report." In Antiphospholipid Syndrome. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55442-6_18.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Antiphospholipid syndrome"

1

Vrbanec, Kristina, Igor Antončić, David Bonifačić, Siniša Dunatov, and Lidija Tuškan-Mohar. "Antiphospholipid syndrome." In NEURI 2015, 5th Student Congress of Neuroscience. Gyrus JournalStudent Society for Neuroscience, School of Medicine, University of Zagreb, 2015. http://dx.doi.org/10.17486/gyr.3.2236.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Mohammed, Mohammed H., and Mark S. Lingenfelter. "Catastrophic Antiphospholipid Syndrome (CAPS): A Rare Fatal Complication Of Antiphospholipid Syndrome." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a3178.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Santos Melo, Tâmara, Robson Antônio Gonçalves, Valéria Bezerra da Silva, et al. "CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME: CASE REPORT." In SBR 2021 Congresso Brasileiro de Reumatologia. Sociedade Brasileira de Reumatologia, 2021. http://dx.doi.org/10.47660/cbr.2021.2198.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Marra, Paula Santana, Clara Ribeiro Doria, Sebastian David Córdoba Duran, et al. "REFRACTORY PEDIATRIC CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME." In XLI Congresso Brasileiro de Reumatologia. Sociedade Brasileira de Reumatologia, 2024. https://doi.org/10.47660/cbr.2024.2342.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Franco, Paula Yanca Souza, Lucilaine Furtado Hermenegildo, Aurélio Rosa Borges, Taciana Fernandes Araújo Ferreira, and Inara Julian Gato de Morais. "CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME: CASE REPORT." In XLI Congresso Brasileiro de Reumatologia. Sociedade Brasileira de Reumatologia, 2024. https://doi.org/10.47660/cbr.2024.1758.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Aydi, Z., Z. Hadj Ali, I. Rachdi, et al. "59 Antiphospholipid syndrome: about 62 cases." In LUPUS 2017 & ACA 2017, (12th International Congress on SLE &, 7th Asian Congress on Autoimmunity). Lupus Foundation of America, 2017. http://dx.doi.org/10.1136/lupus-2017-000215.59.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Worm Furtado, Andrea, Afonso Guilherme Schmidt, Larissa Vargas Cruz, et al. "Catastrophic antiphospholipid syndrome with hemorrhagic alveolitis." In SBR 2021 Congresso Brasileiro de Reumatologia. Sociedade Brasileira de Reumatologia, 2021. http://dx.doi.org/10.47660/cbr.2021.1891.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Pombo, ME, R. Merino, D. Pascual, MV Cuesta, A. Aguado, and J. García-Consuegra. "AB0102 Antiphospholipid syndrome (aps) in children." In Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.236.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

MELO, ELISA FERNANDES DE, VINICIUS VERLANGIERI SOUBIHE, RAYLANE SHELLYDA DE ALMEIDA ANATE, et al. "CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME WITH FAVORABLE OUTCOME." In 36º Congresso Brasileiro de Reumatologia. Editora Blucher, 2019. http://dx.doi.org/10.5151/sbr2019-047.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Araújo, Daniele Kelle Lopes de, Sanna Paula Pires Mariano Campos, Izabelly Ferreira de Andrade, et al. "CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME: A MULTIFACETED CHALLENGE." In XLI Congresso Brasileiro de Reumatologia. Sociedade Brasileira de Reumatologia, 2024. https://doi.org/10.47660/cbr.2024.2608.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Antiphospholipid syndrome"

1

Yang, Mingfei. Was Antiphospholipid Syndrome A Risk Factor of Stroke? A Systemic Review and Meta-analysis of Cohort Studies Published in the 21st Centur. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.8.0074.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Radić, Mislav, Hana Đogaš, Tina Bečić, Andrea Gelemanovic, Damir Fabijanić, and Josipa Radić. Non-vitamin K oral anticoagulants versus warfarin in patients with triple positive antiphospholipid syndrome – protocol for a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.10.0054.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!